Table 2.

Single score and sum of scores of the 14 panelists for structured report in the second round

Panelist #	A1. Anthropometric data	A2. Personal assessments	A3. Allergies and adverse reactions	B1. Clinical information	C1. Examination data	C2. Contrast agent	C3. Study protocol	C4. Adverse Events	D1.Lesion	D2. Lymphadenopathy	D3. Distant metastasis	D4. Carcinosis	D5. Free payment	D6. Perforation	D7. TNM stage	D8. Accessory findings	Tot
1	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	80
2	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	80
3	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	80
4	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	80
5	5	5	5	4	5	5	5	5	5	4	4	5	5	5	5	5	77
6	5	3	5	5	5	5	5	5	5	5	5	5	4	5	5	5	77
7	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	80
8	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	80
9	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	80
10	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	80
11	4	3	4	5	5	5	5	5	5	5	5	5	5	5	5	3	74
12	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	80
13	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	80
14	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	80
Mean	4.93	4.71	4.93	4.93	5.00	5.00	5.00	5.00	5.00	4.93	4.93	5.00	4.93	5.00	5.00	4.86	79.14
STD	0.27	0.73	0.27	0.27	0.00	0.00	0.00	0.00	0.00	0.27	0.27	0.00	0.27	0.00	0.00	0.53	1.83